CARLSBAD, Calif., Feb. 19, 2021 /PRNewswire/ -- Ionis
Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted
therapeutics, today announced that management will participate in a
virtual fireside chat at the following investor conferences:
- SVB Leerink 10th Annual Global Healthcare Conference
on Friday, February 26, 2021;
- Oppenheimer 31st Annual Healthcare Conference on
Wednesday, March 17, 2021; and
- J.P. Morgan 10th Annual Napa Valley Forum on
Monday, March 29, 2021.
The above listed dates are subject to change. Details on
presentation times or changes to presentation dates can be found on
the Company's website. Please check www.ionispharma.com for the
latest information.
A live webcast of the presentations will be available on the
Investors & Media section of the Ionis website. The replays
will be available within 48 hours and will be archived for a
limited time.
About Ionis Pharmaceuticals
For more than 30 years,
Ionis has been the leader in RNA-targeted therapy, pioneering new
markets and changing standards of care with its novel antisense
technology. Ionis currently has three marketed medicines and a
premier late-stage pipeline highlighted by industry-leading
neurological and cardiometabolic franchises. Our scientific
innovation began and continues with the knowledge that sick people
depend on us, which fuels our vision of becoming one of the most
successful biotechnology companies.
To learn more about Ionis visit www.ionispharma.com and
follow us on twitter @ionispharma.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301231383.html
SOURCE Ionis Pharmaceuticals, Inc.